Breast Cancer

Freiburg, Germany, August 31, 2026 Kazia Therapeutics has announced plans to expand its ongoing paxalisib clinical trial into hormone...

Sydney, Australia, September 1, 2026 Kazia Therapeutics has announced plans to expand its ongoing paxalisib clinical trial into hormone...

Austin, Texas – August 28, 2026 Natera, Inc. announced a new national partnership with Susan G. Komen to accelerate...

TAIPEI, Taiwan — August 25, 2026 Senhwa Biosciences announced that it has completed patient enrollment in its Phase 1b...

CHENGDU, China — August 17, 2026 Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (Kelun-Biotech) reported its unaudited interim results for the...

Toronto, Canada and Dallas, Texas, August 13, 2026 Perimeter Medical Imaging AI Inc. has announced that Intermountain Health has...

Caesarea, Israel, August 13, 2026 IceCure Medical Ltd., a developer of minimally invasive cryoablation technology for tumor treatment, has...

South San Francisco, California, August 13, 2026 Rigel Pharmaceuticals, Inc. announced the U.S. commercial availability of VEPPANU™ (vepdegestrant) for...

BRISBANE, Calif., August 12, 202 Annexon, Inc. announced the expansion of its ongoing Phase 3 ARCHER II trial evaluating...

BOTHELL, Wash., August 12, 2026 LeonaBio, Inc. announced that its lead investigational therapy lasofoxifene will be featured in multiple...